Emerging VC Funds
Build your investment pipeline from day one without hiring a dedicated sourcing team.
Deal Flow Services
Expand Your Deal Flow
Without Expanding Your Team.
Your Healthcare & Life Sciences Deal Sourcing Partner.
DealBio helps investment funds discover, qualify, and monitor biotech, healthtech and medtech investment opportunities tailored to their investment thesis.
We combine AI-powered research and human expertise to deliver curated startup opportunities, investment intelligence and continuous company monitoring directly to your team.
WHO WE WORK WITH
From Emerging Funds to Established Investors.
Established VC Funds
Complement your existing deal flow with new opportunities beyond your current network and sourcing channels.
Funds Expanding Internationally
Discover startups in new countries and ecosystems without establishing a local sourcing presence in every market.
Funds Exploring New Therapeutic Areas
Map emerging companies, technologies, and investment opportunities in therapeutic areas outside your existing coverage.
Family Offices & Direct Investors
Access curated healthcare and life sciences investment opportunities without building a full in-house research function.
Corporate Venture Capital & Venture Builders
Source emerging technologies and research-driven ventures for investment and new company creation.
Why Partner With DealBio?
Expand Your Deal Flow. Reduce Your Workload.
01
More Investment Opportunities
Access a recurring pipeline of startups aligned with your investment priorities.
02
Broader Geographic Coverage
Discover opportunities across markets your investment team may not systematically cover.
03
Earlier Discovery
Identify emerging startups and scientific innovations at an earlier stage of development.
04
Less Time Spent Sourcing
Reduce the time spent searching for startups, gathering company information, and preparing initial research.
05
No Additional Headcount
Extend your sourcing capabilities without hiring additional investment analysts.
06
More Informed Decisions
Access alternative investments, funding comparables, and exit precedents alongside each opportunity.
07
Continuous Pipeline Monitoring
Stay informed about promising startups through automated monitoring and regular founder check-ins.
08
Fully Managed Service
We handle sourcing, research, and monitoring. Your team decides which opportunities warrant deeper evaluation.
What You Get
Curated Investment Opportunities, Backed by Relevant Research.
Each opportunity is delivered with the information your team needs to understand the company, assess its relevance, and identify potential alternatives.
DealBio
Each startup brief includes:
Company Overview
Business, technology, therapeutic area, development stage, and geography.
Investment Thesis Fit
Why the company matches your specific investment criteria.
Founder & Team Information
Key people and relevant backgrounds.
Funding Information
Previous rounds, investors, and available fundraising signals.
Alternative Investments
Other potentially investable startups pursuing comparable approaches.
Funding Comparables
Similar companies that have raised capital.
Exit Comparables
Relevant acquisitions and exits in the sector.
Latest Developments
Scientific, clinical, commercial, and strategic milestones.
Sources & Verification
Supporting references and available verification details.
We handle the discovery, research, and monitoring. Your team receives the results in a format that fits its existing workflow.
DealBio
How We Build Your Deal Flow
01
Deal Sourcing
Expand Your Pipeline with Thesis-Matched Startups.
We search across startup ecosystems, universities, research institutions, and emerging markets to identify companies that fit your investment criteria. Each opportunity is researched and screened before reaching your team.
What we do:
- Startup Discovery
- Identify emerging biotech, medtech, and healthtech companies across startup ecosystems, universities, research institutions, incubators, and other relevant sources.
- Thesis-Based Screening
- Filter opportunities by therapeutic area, technology, development stage, geography, funding requirements, and your specific investment criteria.
- Initial Qualification
- Research founders, technologies, company maturity, funding history, and relevant developments.
- Founder Verification
- Contact selected startups to clarify key information, including fundraising plans, development milestones, and investment readiness.
- Founder Introductions
- Facilitate introductions between your investment team and interested founders.
02
Deal Intelligence
See How Every Opportunity Compares.
For each startup we source, we research alternative investment opportunities, comparable funding rounds, and relevant exits to give your team a clearer picture of the investment landscape.
What we provide:
- Alternative Investment Opportunities
- Discover startups addressing similar medical needs or developing competing technologies, across your target markets and other relevant geographies.
- Funding Comparables
- Identify similar companies that have raised capital, including funding rounds, amounts, dates, and participating investors.
- Exit Comparables
- Explore relevant acquisitions and exits, including strategic acquirers, transaction dates, and disclosed transaction values where available.
03
Deal Monitoring
Never Lose Track of a Promising Investment Opportunity.
Not every promising startup is ready for investment today. We help you stay informed as companies evolve, reach important milestones, and approach new financing rounds.
What we do:
- Continuous AI Monitoring
- Track selected startups for important scientific, clinical, regulatory, commercial, and financing developments.
- Milestone Tracking
- Monitor key developments that may change a startup's investment relevance.
- Fundraising Signals
- Identify indications of upcoming or ongoing fundraising activity.
- Regular Founder Check-ins
- Maintain contact with selected founders to obtain updates on company progress, upcoming milestones, and fundraising plans.
- Timely Alerts
- Notify your team when meaningful developments warrant attention or renewed contact.
How We Work
A Sourcing Process Built Around Your Investment Thesis.
- 01
Understand Your Investment Strategy
We begin with a short discussion to understand your investment focus, target geographies, stages, technologies, therapeutic areas, and sourcing priorities.
- 02
Build Your Sourcing Scope
We configure our research and monitoring processes around your criteria, including relevant sources, markets, and exclusions.
- 03
Discover, Research & Qualify
Our AI-powered workflows identify potential opportunities. We review and research selected companies before delivering them to your team.
- 04
Deliver & Refine
You receive curated startup opportunities and investment intelligence.
- 05
Verify & Connect
For selected opportunities, we conduct additional founder outreach to verify information and facilitate introductions when there is mutual interest.
- 06
Monitor & Update
We monitor selected companies, track important milestones, and conduct regular founder check-ins to keep your investment pipeline current.
Free Pilot Program
Join Our Free Pilot Program
We're inviting three VC funds focused on healthcare and life sciences to join our free pilot program and receive investment opportunities tailored to their investment thesis.
During the pilot, you'll receive:
- Startup sourcing tailored to your investment thesis
- Regular delivery of researched investment opportunities
- Alternative investments, funding comparables, and exit comparables
- Monitoring of a selected startup watchlist
- Selected founder verification and introduction support
- Direct collaboration with our team to align sourcing with your priorities
Minimal Time Commitment.
We start with a short introductory call to understand your priorities.
From there, DealBio handles the research, sourcing, and delivery. We simply ask for brief feedback to ensure the opportunities remain relevant to your fund.
Decide Based on the Actual Results.
At the end of the pilot, we'll review the results together. If you see value in continuing, we can discuss an ongoing partnership. If not, the pilot ends there, with no obligation to continue and no sales pressure.
FAQ
Frequently Asked Questions
We already have an internal sourcing team. Why would we need DealBio?
DealBio is designed to complement your existing team, not replace it.
We help expand your sourcing coverage across additional markets, technologies, and ecosystems while reducing the time spent on manual research.
What if we already know the startups you identify?
Before starting, we define your investment criteria, sourcing priorities, and exclusions.
Your feedback helps us minimize overlap with your existing pipeline and focus on identifying additional opportunities.
While we cannot guarantee that every company will be new to your team, discovering relevant opportunities beyond your existing deal flow is one of the main outcomes we aim to demonstrate.
How is DealBio different from PitchBook, Crunchbase, or other sourcing platforms?
DealBio combines specialized healthcare and life sciences sourcing with a fully managed service.
Rather than providing another database or research platform, we handle startup discovery, initial qualification, investment intelligence, and ongoing monitoring, then deliver researched opportunities directly to your team.
Our approach combines AI-powered research with human verification, regular founder check-ins, and founder introductions.
How much time will we need to dedicate to the pilot?
We begin with a 15-minute discussion to understand your investment priorities.
From there, we manage the sourcing and research, requesting only brief feedback to refine the results.
No technical integration or extensive onboarding is required.
How do you ensure the startups match our investment thesis?
We establish your investment criteria before sourcing begins, including stage, geography, therapeutic area, technology, funding requirements, and other preferences.
We screen opportunities against those criteria and continuously refine our selection based on your feedback.
Do you contact startups directly?
Yes. We can contact selected founders to verify company information, understand fundraising timelines, obtain progress updates, and facilitate introductions.
We coordinate fund-specific outreach with your team and obtain founder consent before making introductions.
What does Deal Monitoring include?
We combine continuous automated monitoring with regular founder check-ins for selected startups.
We track important developments, financing signals, and company milestones, then notify your team when a startup becomes investable based on your criteria.
Is DealBio's research a substitute for due diligence?
No. We provide initial qualification, investment intelligence, and source-backed company research to support your investment team's evaluation process.
Scientific, clinical, financial, and legal due diligence remain the responsibility of the investor and its appointed advisers.
Is our investment thesis and pipeline information confidential?
Yes. We treat fund-specific information confidentially and agree on how your sourcing criteria, company information, and feedback may be used.
What happens after the pilot ends?
We review the results together and discuss your feedback.
If you see value in continuing, we can explore an ongoing paid sourcing partnership.
There is no obligation to proceed and no commercial pressure. If you decide not to continue, the pilot simply ends.
Your Investment Thesis. Our Sourcing Engine.
More Deal Flow. Deeper Investment Intelligence. Continuous Monitoring.